Results 141 to 150 of about 1,613,605 (358)

Fluid and Neuroimaging Biomarkers in Microgliopathy Colony‐Stimulating Factor‐1 Receptor‐Related Disorders

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aims to identify both fluid and neuroimaging biomarkers for CSF1R‐RD that can inform the optimal timing of treatment administration to maximize therapeutic benefit, while also providing sensitive quantitative measurements to monitor disease progression.
Tomasz Chmiela   +13 more
wiley   +1 more source

Effect of Gene Polymorphism on the Pharmacokinetics and Clinical Outcomes of Rivaroxaban: State-of-the-Art Review

open access: yesDrug Design, Development and Therapy
Ling Wang,1,2,* Guoquan Chen,2,* Wei Hu,3,* Jiale Chen,2 Yiling He1,2 1School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, People’s Republic of China; 2Department of Pharmacy, Affiliated Jinhua ...
Wang L, Chen G, Hu W, Chen J, He Y
doaj  

Aspects of pharmaceutical care for patients with cephalgia in specialized neurology clinics

open access: yesРеальная клиническая практика: данные и доказательства
Objective. To determine the characteristics of pharmaceutical care for patients with headache in specialized neurology clinics.Materials and methods.
O. V. Reshetko   +3 more
doaj   +1 more source

Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer   +14 more
wiley   +1 more source

Efficient Colon Cancer Immunogene Therapy Through Co-Delivery of IL-22BP mRNA and Tumor Cell Lysate by CLSV Nanoparticles [Retraction]

open access: yesInternational Journal of Nanomedicine
Huang J, Wang K, Fu X, et al. Int J Nanomedicine. 2023;18:8059—8075. We, the Editors and Publisher of the International Journal of Nanomedicine, have retracted the published article.
Huang J   +8 more
doaj  

Use of Symptomatic Drug Treatment for Fatigue in Multiple Sclerosis and Patterns of Work Loss

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To describe the use of central stimulants and amantadine for fatigue in MS and evaluate a potential association with reduced work loss in people with MS. Methods We conducted a nationwide, matched, register‐based cohort study in Sweden (2006 to 2023) using national registers with prospective data collection.
Simon Englund   +3 more
wiley   +1 more source

Research Progress of Multifunctional Hydrogels in Promoting Wound Healing of Diabetes

open access: yesInternational Journal of Nanomedicine
Jiansong He, Jiemei Chen, Taotao Liu, Fuli Qin, Weipeng Wei Department of Pharmacy, The First Affiliated Hospital of Guangxi Medical University, Nanning, People’s Republic of ChinaCorrespondence: Weipeng Wei, Department of Pharmacy, The First Affiliated ...
He J, Chen J, Liu T, Qin F, Wei W
doaj  

Survey on the Attitudes of Pharmacy Students in Japan toward Doping and Supplement Intake

open access: diamond, 2013
Yoshitaka Saito   +6 more
openalex   +2 more sources

Post‐COVID Fatigue Is Associated With Reduced Cortical Thickness After Hospitalization

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neuropsychiatric symptoms are among the most prevalent sequelae of COVID‐19, particularly among hospitalized patients. Recent research has identified volumetric brain changes associated with COVID‐19. However, it currently remains poorly understood how brain changes relate to post‐COVID fatigue and cognitive deficits.
Tim J. Hartung   +190 more
wiley   +1 more source

Home - About - Disclaimer - Privacy